We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $299M
1-Year Est. Return 53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
Cap. Flow
+$8.26M
Cap. Flow %
2.77%
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36

Top Buys

Rank Stock Value
1
FHLC icon
Fidelity MSCI Health Care Index ETF
FHLC
+$18.3M
2
SIBN icon
SI-BONE Inc
SIBN
+$3.79M
3
DUOT icon
Duos Technologies
DUOT
+$2.91M
4
APGE
Apogee Therapeutics
APGE
+$2.91M
5
NPCE icon
Neuropace
NPCE
+$1.61M

Top Sells

Rank Stock Value
1
CNTA
Centessa Pharmaceuticals
CNTA
+$9.41M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.14M
3
ANAB icon
AnaptysBio
ANAB
+$3.29M
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$1.64M
5
PIPR icon
Piper Sandler
PIPR
+$1.27M

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.9%
2 Healthcare 21.84%
3 Technology 4.77%
4 Financials 3.58%
5 Industrials 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRWG icon
401
GrowGeneration
GRWG
$97.2M
$4.44K ﹤0.01%
3,000
– –
IXUS icon
402
iShares Core MSCI Total International Stock ETF
IXUS
$61.4B
$4.39K ﹤0.01%
46
– –
RIOT icon
403
Riot Platforms
RIOT
$8.18B
$4.38K ﹤0.01%
160
– –
EBAY icon
404
eBay
EBAY
$46B
$4.36K ﹤0.01%
39
– –
ACN icon
405
Accenture
ACN
$114B
$4.36K ﹤0.01%
35
+15
+75% +$2.6K
ELF icon
406
e.l.f. Beauty
ELF
$6.47B
$4.32K ﹤0.01%
58
– –
BMRN icon
407
BioMarin Pharmaceuticals
BMRN
$12.9B
$4.29K ﹤0.01%
75
– –
ALNY icon
408
Alnylam Pharmaceuticals
ALNY
$35.6B
$4.21K ﹤0.01%
14
– –
QBTS icon
409
D-Wave Quantum Inc
QBTS
$6.18B
$4.2K ﹤0.01%
175
+10
+6% +$219
OMCL icon
410
Omnicell
OMCL
$1.57B
$4.15K ﹤0.01%
100
– –
SNDL icon
411
Sundial Growers
SNDL
$358M
$4.05K ﹤0.01%
3,000
– –
OXY icon
412
Occidental Petroleum
OXY
$60B
$4.03K ﹤0.01%
83
– –
CNP icon
413
CenterPoint Energy
CNP
$26.1B
$4.01K ﹤0.01%
+91
New +$3.9K
NOW icon
414
ServiceNow
NOW
$146B
$3.97K ﹤0.01%
92
+47
+104% +$4.65K
ARKF icon
415
ARK Blockchain & Fintech Innovation ETF
ARKF
$834M
$3.95K ﹤0.01%
100
– –
ALL icon
416
Allstate
ALL
$65.6B
$3.92K ﹤0.01%
16
– –
OCUL icon
417
Ocular Therapeutix
OCUL
$2.34B
$3.9K ﹤0.01%
397
– –
SLB icon
418
SLB Ltd
SLB
$85.3B
$3.89K ﹤0.01%
84
-33
-28% -$1.77K
CRWV
419
CoreWeave
CRWV
$49.3B
$3.88K ﹤0.01%
39
-15
-28% -$1.62K
STZ icon
420
Constellation Brands
STZ
$21.9B
$3.76K ﹤0.01%
27
+25
+1,250% +$3.72K
NWG icon
421
NatWest
NWG
$75.2B
$3.76K ﹤0.01%
213
-89
-29% -$1.43K
GEVO icon
422
Gevo
GEVO
$405M
$3.75K ﹤0.01%
2,500
– –
KMB icon
423
Kimberly-Clark
KMB
$34.9B
$3.73K ﹤0.01%
+34
New +$3.37K
INDA icon
424
iShares MSCI India ETF
INDA
$6.75B
$3.73K ﹤0.01%
76
– –
PYPL icon
425
PayPal
PYPL
$47B
$3.64K ﹤0.01%
84
– –
15 16
17
18 19

Similar funds

GWM
Glass Wealth Management San Antonio, Texas $299M AUM 66.9% 1-Year Est. Return
HP
Highlander Partners Dallas, Texas $298M AUM 53.88% 1-Year Est. Return
SFS
Searcy Financial Services Overland Park, Kansas $298M AUM 20.59% 1-Year Est. Return
SIA
Schear Investment Advisers Cincinnati, Ohio $299M AUM 90.52% 1-Year Est. Return
MWM
Maltin Wealth Management Ridgewood, New Jersey $299M AUM 22.87% 1-Year Est. Return
WFA
Woodward Financial Advisors Chapel Hill, North Carolina $299M AUM
SC
Sawyer & Company Boston, Massachusetts $298M AUM 31.71% 1-Year Est. Return
KWA
Kondo Wealth Advisors Pasadena, California $299M AUM 21.97% 1-Year Est. Return

HighMark Wealth Management's Q2 2026 Portfolio in Review

As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.

By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.

  • HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
  • HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
  • HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
  • HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
  • HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
  • HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.